Latest Period
Q4 2025
Security Snapshot
MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) Institutional Ownership
CUSIP: 56565P103
13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026
Institutions Reporting
74
Shares (Excl. Options)
23,065,711
Price
$17.56
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / COMMON STOCK
- Symbol
- MPLT on Nasdaq
- Shares outstanding
- 45,148,065
- Price per share
- $26.73
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 23,065,711
- Total reported value
- $405,121,994
- % of total 13F portfolios
- 0.01%
- Share change
- +23,062,256
- Value change
- +$405,061,184
- Number of holders
- 74
- Price from insider filings
- $26.73
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- MPLT - MapLight Therapeutics, Inc. - COMMON STOCK is tracked under CUSIP 56565P103.
- 74 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 74 to 34 between Q4 2025 and Q1 2026.
- Reported value moved from $405,121,994 to $81,576,249.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 74 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 56565P103?
CUSIP 56565P103 identifies MPLT - MapLight Therapeutics, Inc. - COMMON STOCK in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 56565P103:
Significant Owners of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Catalyst4, Inc. | 45% | $361,842,414 | 19,697,464 | Catalyst4, Inc. | 28 Oct 2025 | |||
| Novo Holdings A/S | 8.4% | 3,686,622 | Novo Holdings A/S | 28 Oct 2025 | ||||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.1% | $61,527,448 | 3,226,400 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 31 Dec 2025 | |||
| T. Rowe Price Investment Management, Inc. | 6.2% | $53,380,363 | 2,799,180 | T. Rowe Price Investment Management, Inc. | 31 Dec 2025 |
As of 31 Dec 2025, 74 institutional investors reported holding 23,065,711 shares of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT). This represents 51% of the company’s total 45,148,065 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 8.2% | 3,686,622 | 5% | $64,755,515 | |
| FCPM III SERVICES B.V. | 7.1% | 3,226,400 | 7.4% | $56,671,716 | |
| T. Rowe Price Investment Management, Inc. | 6.2% | 2,799,180 | 0.03% | $49,168,000 | |
| GOLDMAN SACHS GROUP INC | 4.3% | 1,937,168 | 0% | $34,026,356 | |
| BlackRock, Inc. | 2.4% | 1,095,514 | 0% | $19,242,704 | |
| Nan Fung Group Holdings Ltd | 2.2% | 971,253 | 15% | $17,060,059 | |
| 5AM Venture Management, LLC | 2.1% | 950,011 | 5.2% | $16,686,943 | |
| Sanofi | 2% | 912,041 | 5.2% | $16,020,000 | |
| VANGUARD GROUP INC | 1.9% | 869,668 | 0% | $15,275,718 | |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.4% | 611,447 | 4.2% | $10,743,124 | |
| PERCEPTIVE ADVISORS LLC | 1.2% | 550,000 | 0.18% | $9,660,750 | |
| Velan Capital Investment Management LP | 1.2% | 522,305 | 5.3% | $9,174,288 | |
| Siren, L.L.C. | 1% | 450,000 | 0.24% | $7,904,250 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.86% | 389,026 | 0% | $6,834,870 | |
| Vestal Point Capital, LP | 0.85% | 385,000 | 0.25% | $6,762,525 | |
| BAKER BROS. ADVISORS LP | 0.81% | 364,705 | 0.04% | $6,406,043 | |
| Jain Global LLC | 0.73% | 327,693 | 0.06% | $5,755,928 | |
| Blue Owl Capital Holdings LP | 0.72% | 327,058 | 1.8% | $5,744,774 | |
| STATE STREET CORP | 0.51% | 229,484 | 0% | $4,030,886 | |
| LAZARD ASSET MANAGEMENT LLC | 0.46% | 207,494 | 0.01% | $3,644,632 | |
| Board of Trustees of The Leland Stanford Junior University | 0.44% | 199,233 | 0.71% | $3,499,527 | |
| CITADEL ADVISORS LLC | 0.42% | 190,139 | 0% | $3,339,792 | |
| Freestone Grove Partners LP | 0.41% | 183,771 | 0.02% | $3,227,938 | |
| Tetragon Partners GP Ltd | 0.36% | 164,525 | 0.61% | $2,889,882 | |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.33% | 147,930 | 0% | $2,598,000 |